Description

Dasatinib Tablets 70mg are used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). This targeted therapy inhibits specific tyrosine kinases, effectively blocking cancer cell growth and improving patient outcomes by enhancing overall survival rates during treatment.